CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus

The CADTH Canadian Drug Expert Committee (CDEC) recommends that canagliflozin and metformin hydrochloride (canagliflozin/metformin) be reimbursed for patients with type 2 diabetes mellitus provided that criterion and condition are met

Corporate Authors: CADTH Canadian Drug Expert Committee, Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2016, August 25, 2016
Series:Common drug review
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Summary:The CADTH Canadian Drug Expert Committee (CDEC) recommends that canagliflozin and metformin hydrochloride (canagliflozin/metformin) be reimbursed for patients with type 2 diabetes mellitus provided that criterion and condition are met
Physical Description:1 PDF file (5 pages)